| Heather A Ferris, MD, PHD | |
|
183 Spotnap Rd Ste A, Charlottesville, VA 22911-8812 | |
| (434) 293-7811 | |
| (434) 293-7818 |
| Full Name | Heather A Ferris |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 18 Years |
| Location | 183 Spotnap Rd Ste A, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598959348 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
Adi Mehta, MD stresses the growing severity of the metabolic syndrome in the May 2010 edition of Postgraduate Medicine. Metabolic syndrome often leads to cardiovascular disease (CVD) because of its key components: diabetes, dyslipidemia, and hypertension. With obesity maintaining its status as a huge problem worldwide, physicians must act as soon as possible when they recognize metabolic syndrome or any of its components.
Indiana University researchers found promising results in an exploratory study involving yoga practice by older adults who expressed a fear of falling.
Changes in the circumstances of when organs are donated to pediatric patients has resulted in a decreased number of organ transplant wait-list deaths over the past decade, according to research published online this week in the journal Pediatrics.
Idera Pharmaceuticals, Inc. today presented data on the mechanism of action of IMO-3100, an antagonist of Toll-like Receptor (TLR) 7 and TLR9, in a preclinical primate model at the Keystone Symposia conference "Tolerance and Autoimmunity" being held February 21-26 in Taos, New Mexico. Idera is developing IMO-3100 for the treatment of autoimmune diseases. The presentation entitled "IMO-3100, a novel antagonist, suppresses TLR7- and TLR9-mediated immune responses in non-human primates" was made by Idera scientists.
People who have a mother with Alzheimer's disease appear to be at higher risk for getting the disease than those individuals whose fathers are afflicted, according to a new study by NYU School of Medicine researchers.
› Verified 8 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
Adi Mehta, MD stresses the growing severity of the metabolic syndrome in the May 2010 edition of Postgraduate Medicine. Metabolic syndrome often leads to cardiovascular disease (CVD) because of its key components: diabetes, dyslipidemia, and hypertension. With obesity maintaining its status as a huge problem worldwide, physicians must act as soon as possible when they recognize metabolic syndrome or any of its components.
Indiana University researchers found promising results in an exploratory study involving yoga practice by older adults who expressed a fear of falling.
Changes in the circumstances of when organs are donated to pediatric patients has resulted in a decreased number of organ transplant wait-list deaths over the past decade, according to research published online this week in the journal Pediatrics.
Idera Pharmaceuticals, Inc. today presented data on the mechanism of action of IMO-3100, an antagonist of Toll-like Receptor (TLR) 7 and TLR9, in a preclinical primate model at the Keystone Symposia conference "Tolerance and Autoimmunity" being held February 21-26 in Taos, New Mexico. Idera is developing IMO-3100 for the treatment of autoimmune diseases. The presentation entitled "IMO-3100, a novel antagonist, suppresses TLR7- and TLR9-mediated immune responses in non-human primates" was made by Idera scientists.
People who have a mother with Alzheimer's disease appear to be at higher risk for getting the disease than those individuals whose fathers are afflicted, according to a new study by NYU School of Medicine researchers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather A Ferris, MD, PHD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Heather A Ferris, MD, PHD 183 Spotnap Rd Ste A, Charlottesville, VA 22911-8812 Ph: (434) 293-7811 |
News Archive
Adi Mehta, MD stresses the growing severity of the metabolic syndrome in the May 2010 edition of Postgraduate Medicine. Metabolic syndrome often leads to cardiovascular disease (CVD) because of its key components: diabetes, dyslipidemia, and hypertension. With obesity maintaining its status as a huge problem worldwide, physicians must act as soon as possible when they recognize metabolic syndrome or any of its components.
Indiana University researchers found promising results in an exploratory study involving yoga practice by older adults who expressed a fear of falling.
Changes in the circumstances of when organs are donated to pediatric patients has resulted in a decreased number of organ transplant wait-list deaths over the past decade, according to research published online this week in the journal Pediatrics.
Idera Pharmaceuticals, Inc. today presented data on the mechanism of action of IMO-3100, an antagonist of Toll-like Receptor (TLR) 7 and TLR9, in a preclinical primate model at the Keystone Symposia conference "Tolerance and Autoimmunity" being held February 21-26 in Taos, New Mexico. Idera is developing IMO-3100 for the treatment of autoimmune diseases. The presentation entitled "IMO-3100, a novel antagonist, suppresses TLR7- and TLR9-mediated immune responses in non-human primates" was made by Idera scientists.
People who have a mother with Alzheimer's disease appear to be at higher risk for getting the disease than those individuals whose fathers are afflicted, according to a new study by NYU School of Medicine researchers.
› Verified 8 days ago
Daniel S. Strand, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1240 Lee St, Charlottesville, VA 22908 Phone: 434-243-5233 Fax: 434-244-7526 | |
Dr. Numaan F. Malik, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Lee St Fl 2, Charlottesville, VA 22908 Phone: 434-924-5219 Fax: 434-924-9720 | |
Dr. Asma Shahid Habib, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-9119 Fax: 434-924-3300 | |
Amber N. Inofuentes, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-243-4288 Fax: 434-243-7310 | |
Mark Thomas Worthington, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-243-3090 Fax: 434-244-9445 | |
Dr. Emanuel Cirenza, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 590 Peter Jefferson Place, Suite 175, Charlottesville, VA 22911 Phone: 434-982-6900 Fax: 434-982-8420 | |
Warren K. Bolton, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: Uva Hospital W, Hospital Drive, Charlottesville, VA 22908 Phone: 434-924-1984 Fax: 434-924-5898 |